Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Without a news event this stock just gets caught in any downdraft and even in bettertimes is subject to pretty wide swings. It is a good one to trade in more normal times. The recent drop has been extraordinary, being a combination of IBB weakness and the hold in PEG trials. In addition, management has been too reticent in my opinion. For example, after the Hylenex glass in the vials hold, which came out on a Friday, (when was that, about two years ago?) the company immediately held a c/c the following Monday to explain all the facts as they knew them. This helped to stem the panic and put a floor under the stock price. Now, after the PEG news, institutions got out after the news of the hold and the pps is still looking for a bottom yet to be found. I think your vol/price line is as good as a defensive line as any but we will continue to suffer weakness until some favorable news hits the wires, IMHO.
Good luck!
-Fritz